drugset / Trial / NCT00391716

Gabapentin Treatment of Alcohol Dependence

NCT00391716

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Gabapentin treatment for alcohol dependence

Timeline

Start
2004-02
Primary completion
2009-07
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 900 mg Oral
Subject Gabapentin Small molecule 1800 mg Oral

Indications